UNIPHARMA ApS: Financial statements 2022
CVR: 78881917
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
UNIPHARMA ApS (CVR 78881917) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 0 and a net result of DKK -88 compared with DKK -5,190 the year before. Equity in the 2022 report amounted to DKK 56,457. The solvency ratio was 31.3%.
- Revenue
- DKK 0
- Gross Profit
- DKK 0
- Profit/Loss
- DKK -88
- Equity
- DKK 56,457
- Total Assets
- DKK 180,502
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | 0 | 0 | -88 | 56 t. | - |
| 2021 | - | - | -5 t. | 57 t. | - |
| 2020 | -5 t. | -5 t. | -5 t. | 62 t. | - |
| 2019 | -5 t. | -5 t. | -5 t. | 67 t. | - |
| 2018 | -10 t. | -10 t. | -10 t. | 72 t. | - |
Official annual report
Keep an eye on UNIPHARMA ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
UNIPHARMA ApS has published its annual report for 2021. The net result was DKK -5,190.
About UNIPHARMA ApS
UNIPHARMA ApS is a Danish company of the type Anpartsselskab based in København K, founded in 1985. The company is under bankruptcy. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company is owned by Ebba Dorrit Reumert. According to the 2023 annual report, the company had an average of 0 employees. In 2024, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK 0 the year before. Equity in the 2024 report amounted to DKK -124,033.